Ipamorelin (10mg)

Ipamorelin is a synthetic research peptide supplied for laboratory and analytical chemistry applications. This material is intended for controlled research environments where peptide identity, sequence characteristics, molecular structure, solubility, stability, and analytical profile may be evaluated using appropriate laboratory methods.

Ipamorelin is typically supplied as a lyophilized powder and should be handled according to standard laboratory procedures for synthetic peptide materials. This product description is strictly chemistry-focused and intended for informational research-use positioning only.

Chemical Profile

Product Name: Ipamorelin 10mg
CAS Number: 170851-70-4
Compound Type: Synthetic Research Peptide
Peptide Class: Modified Short-Chain Peptide / Pentapeptide
Physical Form: Lyophilized Powder
Product Size: 10mg
Research Category: Peptide Chemistry / Analytical Research
Molecular Formula: C38H49N9O5
Molecular Weight: 711.86 g/mol
Sequence Reference: Aib-His-D-2-Nal-D-Phe-Lys-NH2

Ipamorelin is a modified pentapeptide research material with a compact amino acid-based structure. Its final analytical profile may vary depending on salt form, counterion profile, residual moisture, manufacturing process, and batch-specific documentation.

Structural Characteristics

Ipamorelin contains a short modified peptide framework composed of five amino acid residues and terminal amide functionality. The structure includes non-standard amino acid features, aromatic side-chain regions, basic functional groups, and peptide-bond connectivity within a compact molecular framework.

Because modified short-chain peptides can vary by salt form, counterion profile, and supplier documentation, exact molecular formula, molecular weight, sequence confirmation, purity, and assay values should be verified using supplier records or a current lot-specific certificate of analysis when available.

Analytical Considerations

Ipamorelin may be evaluated using standard analytical methods commonly applied to synthetic peptide research materials. These may include identity confirmation, chromatographic purity assessment, mass verification, appearance inspection, and batch consistency review.

Batch-specific values such as purity percentage, assay amount, residual solvents, water content, heavy metals, microbial limits, counterion profile, or pass/fail results should only be stated when supported by a current lot-specific certificate of analysis. In the absence of a COA, analytical language should remain general and informational.

Handling & Storage

Ipamorelin should be handled only in an appropriate laboratory setting using procedures suitable for synthetic peptide materials. The vial should remain sealed when not in use and should be protected from unnecessary exposure to moisture, air, direct light, and elevated temperatures.

Recommended storage and handling considerations include:

• Store sealed and dry
• Protect from direct light
• Minimize exposure to humidity
• Maintain cold-storage conditions for long-term stability
• Avoid repeated temperature cycling
• Minimize exposure to open air
• Handle with appropriate laboratory PPE
• Follow applicable laboratory safety procedures

Storage behavior may vary depending on salt form, residual moisture, container closure, and batch-specific documentation.

Research Use Disclaimer

Ipamorelin 10mg is intended for laboratory research use only. It is not intended for human or animal consumption, clinical use, diagnostic use, food use, supplement use, cosmetic use, household use, or any application outside of controlled research environments.